V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220005909 | 220002303 | 1.59 | 81.5 | Curative (C) | 2013-02-20 | 2013-02-23 | AML 19 TRIAL | 01 | N | 220029230 | AML19 TRIAL |
| 220005910 | 220002304 | 1.8 | 0 | Curative (C) | 2015-07-03 | 2015-07-03 | null | N | N | 220029232 | NOT MATCHED |
| 220005911 | 220002305 | 1.63 | 53.6 | Curative (C) | 2015-06-01 | 2015-06-02 | FLAG + Idarubicin | null | null | 220029234 | FLAG + IDARUBICIN |
| 220005912 | 220002305 | 0 | 76 | Curative (C) | 2013-02-25 | 2013-03-02 | AML MyeChild 01 A Mitozantrone/Cytarabine | N | N | 220029234 | NOT MATCHED |
| 220005913 | 220002305 | 1.6 | 1.8 | Curative (C) | 2017-10-19 | 2017-10-19 | FBC Conditionining | N | N | 220029234 | NOT MATCHED |
| 220005914 | 220002305 | 1.63 | null | Disease modification (D) | 2013-12-03 | 2013-12-04 | FLAG + Idarubicin | N | N | 220029234 | FLAG + IDARUBICIN |
| 220005915 | 220002306 | 1.74 | 66.6 | Curative (C) | 2015-04-11 | 2015-04-11 | AML 19 TRIAL | 1 | N | 220029244 | AML19 TRIAL |
| 220005916 | 220011284 | null | null | Curative (C) | 2015-11-23 | 2015-11-24 | Nilotinib | N | N | 220029246 | NILOTINIB |
| 220005917 | 220002307 | 1.68 | 91 | Curative (C) | 2015-04-28 | 2015-04-29 | AML 19 TRIAL | Y | N | 220029247 | AML19 TRIAL |
| 220005918 | 220002307 | 1.87 | 92.5 | Curative (C) | 2014-12-11 | 2014-12-11 | AML 19 TRIAL | Y | N | 220029247 | AML19 TRIAL |
| 220005919 | 220002307 | 1.67 | 98.9 | Curative (C) | 2012-09-16 | 2013-07-04 | FLAG + Idarubicin | 2 | N | 220029247 | FLAG + IDARUBICIN |
| 220005920 | 220002307 | null | 0 | Neo-adjuvant (N) | 2014-08-29 | 2014-08-29 | AML Interim Guidelines FLA | null | Y | 220029247 | NOT MATCHED |
| 220005921 | 220002308 | null | null | Disease modification (D) | null | 2016-05-08 | Nilotinib | N | N | 220029257 | NILOTINIB |
| 220005922 | 220002308 | 1.6 | 82.2 | Curative (C) | 2015-05-29 | 2015-05-29 | AML Interim Guidelines FLAG-Ida | N | N | 220029257 | FLAG + IDARUBICIN |
| 220005923 | 220002309 | 0 | 0 | Disease modification (D) | null | 2017-07-31 | Nilotinib | N | N | 220029260 | NILOTINIB |
| 220005924 | 220011287 | null | 98 | Curative (C) | 2017-07-24 | 2017-07-26 | Nilotinib | N | N | 220029262 | NILOTINIB |
| 220005925 | 220016052 | 1.67 | null | null | 2014-10-13 | 2014-10-14 | Nilotinib | 2 | N | 220029264 | NILOTINIB |
| 220005926 | 220002310 | 1.78 | 58.4 | Curative (C) | 2014-03-23 | 2014-03-24 | AML 19 TRIAL | Y | N | 220029266 | AML19 TRIAL |
| 220005927 | 220011288 | 1.87 | 58.3 | Curative (C) | 2017-02-04 | 2017-02-06 | AML 19 TRIAL | Y | N | 220029268 | AML19 TRIAL |
| 220005928 | 220011288 | 1.66 | 56.4 | Curative (C) | 2017-08-02 | 2017-08-02 | AML 19 TRIAL | 01 | N | 220029268 | AML19 TRIAL |
| 220005929 | 220011288 | 1.7 | 63.4 | null | 2014-07-18 | 2014-07-18 | FLAG + Idarubicin | 02 | N | 220029268 | FLAG + IDARUBICIN |
| 220005930 | 220002311 | 1.75 | 74 | Curative (C) | 2015-05-31 | 2015-05-31 | AML 19 TRIAL | Y | N | 220029273 | AML19 TRIAL |
| 220005931 | 220002311 | null | null | Curative (C) | null | 2015-01-22 | Nilotinib | N | N | 220029273 | NILOTINIB |
| 220005932 | 220002312 | 1.78 | 53 | Curative (C) | 2015-02-08 | 2015-02-09 | AML 19 TRIAL | Y | N | 220029275 | AML19 TRIAL |
| 220005933 | 220002312 | 1.65 | 0 | Disease modification (D) | 2016-04-19 | 2016-04-23 | Nilotinib | N | N | 220029275 | NILOTINIB |
| 220005934 | 220002312 | null | null | Disease modification (D) | 2014-08-25 | 2015-09-15 | Nilotinib | N | N | 220029275 | NILOTINIB |
| 220005935 | 220002312 | null | 8.7 | Disease modification (D) | 2013-09-17 | 2013-09-17 | null | Y | null | 220029275 | NOT MATCHED |
| 220005936 | 220002313 | 0 | null | Curative (C) | null | 2015-01-18 | Nilotinib | 02 | N | 220029282 | NILOTINIB |
| 220005937 | 220011291 | 0 | 0 | Curative (C) | 2015-12-05 | 2017-03-31 | Nilotinib | 02 | N | 220029285 | NILOTINIB |
| 220005938 | 220016055 | 0 | null | Curative (C) | 2018-02-20 | 2018-02-22 | Nilotinib | N | N | 220029288 | NILOTINIB |
| 220005939 | 220002314 | 1.69 | null | Disease modification (D) | 2017-08-08 | 2017-08-12 | FLAG + Idarubicin | null | N | 220029292 | FLAG + IDARUBICIN |
| 220005940 | 220002314 | null | null | Curative (C) | 2014-06-21 | 2014-06-21 | null | 2 | N | 220029292 | NOT MATCHED |
| 220005941 | 220002314 | 1.75 | 80.2 | Curative (C) | 2014-04-02 | 2014-04-03 | AML 19 TRIAL | Y | N | 220029292 | AML19 TRIAL |
| 220005942 | 220002314 | 1.6 | 50.8 | Curative (C) | 2017-11-22 | 2017-11-24 | AML 19 TRIAL | Y | N | 220029292 | AML19 TRIAL |
| 220005943 | 220002314 | 1.62 | 66 | Curative (C) | 2015-01-13 | 2015-01-13 | AML 19 TRIAL | 1 | N | 220029292 | AML19 TRIAL |
| 220005944 | 220002314 | 0 | null | null | 2013-11-24 | 2013-11-25 | Nilotinib | N | N | 220029292 | NILOTINIB |
| 220005945 | 220002314 | 1.81 | 90 | Curative (C) | 2018-03-15 | 2018-04-10 | Nilotinib | 2 | N | 220029292 | NILOTINIB |
| 220005946 | 220002314 | 1.78 | 30.6 | Curative (C) | 2017-10-15 | 2017-10-17 | APML HR Ind ATO + ATRA | Y | N | 220029292 | NOT MATCHED |
| 220005947 | 220002315 | 1.74 | 0 | Curative (C) | 2014-07-29 | 2014-07-29 | Nilotinib | 02 | N | 220029309 | NILOTINIB |
| 220005948 | 220002315 | null | 100 | Disease modification (D) | 2015-03-30 | 2015-04-01 | Nilotinib | N | N | 220029309 | NILOTINIB |
| 220005949 | 220002315 | 0 | null | Disease modification (D) | null | 2016-08-20 | Nilotinib | N | N | 220029309 | NILOTINIB |
| 220005950 | 220002316 | null | null | Curative (C) | 2016-01-09 | 2016-01-11 | Nilotinib | N | N | 220029315 | NILOTINIB |
| 220005951 | 220002316 | 1.57 | 78 | Curative (C) | 2013-11-10 | 2013-11-10 | AML 19 TRIAL | Y | N | 220029315 | AML19 TRIAL |
| 220005952 | 220002317 | null | null | Palliative (P) | 2013-09-18 | 2013-09-19 | CML Imatinib | N | N | 220029320 | NOT MATCHED |
| 220005953 | 220002317 | 1.78 | 9.6 | Curative (C) | 2016-04-30 | 2016-05-03 | AML Interim Guidelines FLA -Ida | Y | N | 220029320 | NOT MATCHED |
| 220005954 | 220016058 | 0 | 57.6 | null | 2017-12-25 | 2017-12-27 | null | 1 | Y | 220029322 | NOT MATCHED |
| 220005955 | 220018789 | 1.62 | 56.6 | Curative (C) | 2016-09-24 | 2016-09-24 | AML 19 TRIAL | Y | N | 220029326 | AML19 TRIAL |
| 220005956 | 220018789 | 1.53 | 56.9 | Curative (C) | 2017-04-17 | 2017-04-22 | FLAG + Idarubicin | N | N | 220029326 | FLAG + IDARUBICIN |
| 220005957 | 220002318 | 1.75 | 0 | Curative (C) | 2017-08-30 | 2017-09-09 | Nilotinib | 02 | null | 220029328 | NILOTINIB |
| 220005958 | 220002319 | 1.59 | 74.2 | Curative (C) | 2014-01-06 | 2014-01-06 | AML 19 TRIAL | 02 | N | 220029331 | AML19 TRIAL |